Pfizer Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Limited has submitted its financial results for the period ended December 31, 2025 to the stock exchange. This is a routine quarterly results filing as required under listing norms. The actual financial numbers, including revenue, profit after tax, and segment performance, are not detailed in the filing excerpt provided. Shareholders and analysts would need to refer to the full results document for specific performance metrics.
Routine quarterly submission — no immediate material impact on stock price is signaled by the filing itself, though the actual numbers in the detailed results could influence investor sentiment depending on performance versus expectations.